News

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...
The Gates Foundation committed $5.4 billion in 2024, roughly a third of which went to global health programs. Who were the ...
The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.
Bitlayer’s chief, Charlie Hu, made the case for VC support in Bitcoin, emphasizing that early-stage funding drives growth in ...
Andes Technology, the leader in RISC-V processor solutions and a Founding Premier member of RISC-V International, will participate as a Gold Sponsor in the prestigious RISC-V Summit Europe 2025 in ...
India already has a homegrown CAR T-cell therapy, and other regions are exploring their own strategies, including developing them at the point of care.
Home > Pressemitteilung: Medicine meets technology: promoting ... Kurt Alten Foundation supports clinical scientist at MHH in transferring innovative medical-technological approaches to improve liver ...
Poster presentation to demonstrate EBT-107’s potential to reduce clinically-relevant biomarkers and HBV DNA integration toward functional remission of chronic hepatitis B ; Oral ...
LONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced financial and operational ...
NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...
Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing, announces the formation of its ...
Data highlights advantages of single, non-replicative HSV-1 (nrHSV-1) vector hosting two transgenes with independent ...